Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. Healthcare company Myovant Sciences Ltd. (...
Streetwise Reports | June 2, 2020 |

Jayant Bhandari: East Asia Will Be a Post-Pandemic Success

In conversation with Maurice Jackson of Proven and Probable, Jayant Bhandari of Capitalism and Morality offers his take on what the post-COVID-19 world will look like. Maurice Jackson: Joining us for a conversation is Jayant Bhandari, the founder of Capitalism & M...
Streetwise Reports | June 1, 2020 |

Women's Wellness Device Developer Posts In-Line Quarter, Catalysts Looming

A review of this Colorado company's first numbers of the year was provided in a Ladenburg Thalmann report. In a May 13 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Viveve Medical Inc.'s (VIVE:NASDAQ) Q1/19 "reads fine." Q1/19 rev...
Streetwise Reports | May 16, 2019 |

US Biopharma to Launch Phase 3 Trial in Bacterial Vaginosis

Daré Bioscience's study, its prospects and the indication's U.S. market opportunity are discussed in a ROTH Capital Partners report. In a May 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi reviewed why the outlook is positive for Daré Bioscience In...
Streetwise Reports | May 21, 2020 |

Millennials and Baby Boomers – What their Stock Portfolio Reveals

Although millennials are now of age, their influence on the stock market is still in its infancy. The question is, can they produce better results than the older generation, known as baby boomers, who are soon to retire? To get the answer to this question, two stock portf...
Carl Cotton | August 26, 2019 |

Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer ...

Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer Detection and Surgery The disruptive technology is 'poised to deliver significant advancement in bladder cancer detection.' Imagin Medical Inc. (IME:CSE; ...
Streetwise Reports | January 15, 2020 |

Skechers Puts its Best Foot Forward with Record Quarterly Sales

Skechers USA reported record global sales for the second quarter. International sales led the way in the quarter with an increase of 19.8% over the same period last year. Lifestyle and performance footwear company Skechers USA Inc. (SKX:NYSE) reported ...
Streetwise Reports | July 22, 2019 |

Klondike Golden Moments

Foreword: This tale grew from a chance nugget discovery along the shore of a humble Yukon creek carving through the remote Territory and became the great history of the Klondike Gold Rush. Join author James Kwantes as he touches down in the Yukon with 12 exciting stories and c...
James Kwantes | August 15, 2019 |

5 Most Profitable Stocks of Tech Companies in 2019

Apple stocks make up 23.4% of Warren Buffett’s portfolio. He is the most famous and successful money manager of the present days, whose tips and advice are highly embraced by investors. He is the fourth-richest person in the world with a net worth of over $80...
Julia Beyers | November 4, 2019 |

Immuno-oncology Firm to Co-Develop Companion Diagnostic for Cervical Dysplasia

The partnership news and upcoming data readouts are reviewed in an H.C. Wainwright & Co. report. In a May 17 report, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Inovio Pharmaceuticals Inc. (INO:NASDAQ) will collaborate with QIAGEN, a molecula...
Streetwise Reports | May 27, 2019 |
1 2 3 4 5 6 7 8
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested